Open Access

Proteomic profiling of the rat hypothalamus

  • Amanda P Pedroso1,
  • Regina L H Watanabe1,
  • Kelse T Albuquerque1,
  • Mônica M Telles1, 2,
  • Maria C C Andrade1, 3,
  • Juliana D Perez3,
  • Maísa M Sakata3,
  • Mariana L Lima4,
  • Debora Estadella1,
  • Cláudia M O Nascimento1,
  • Lila M Oyama1,
  • José C Rosa5,
  • Dulce E Casarini3 and
  • Eliane B Ribeiro1, 6Email author
Proteome Science201210:26

DOI: 10.1186/1477-5956-10-26

Received: 2 December 2011

Accepted: 20 April 2012

Published: 20 April 2012

Abstract

Background

The hypothalamus plays a pivotal role in numerous mechanisms highly relevant to the maintenance of body homeostasis, such as the control of food intake and energy expenditure. Impairment of these mechanisms has been associated with the metabolic disturbances involved in the pathogenesis of obesity. Since rodent species constitute important models for metabolism studies and the rat hypothalamus is poorly characterized by proteomic strategies, we performed experiments aimed at constructing a two-dimensional gel electrophoresis (2-DE) profile of rat hypothalamus proteins.

Results

As a first step, we established the best conditions for tissue collection and protein extraction, quantification and separation. The extraction buffer composition selected for proteome characterization of rat hypothalamus was urea 7 M, thiourea 2 M, CHAPS 4%, Triton X-100 0.5%, followed by a precipitation step with chloroform/methanol. Two-dimensional (2-D) gels of hypothalamic extracts from four-month-old rats were analyzed; the protein spots were digested and identified by using tandem mass spectrometry and database query using the protein search engine MASCOT. Eighty-six hypothalamic proteins were identified, the majority of which were classified as participating in metabolic processes, consistent with the finding of a large number of proteins with catalytic activity. Genes encoding proteins identified in this study have been related to obesity development.

Conclusion

The present results indicate that the 2-DE technique will be useful for nutritional studies focusing on hypothalamic proteins. The data presented herein will serve as a reference database for studies testing the effects of dietary manipulations on hypothalamic proteome. We trust that these experiments will lead to important knowledge on protein targets of nutritional variables potentially able to affect the complex central nervous system control of energy homeostasis.

Keywords

Hypothalamus Proteome 2-D electrophoresis Mass spectrometry Nutrition Obesity Rat

Background

The hypothalamus plays a pivotal role in numerous mechanisms highly relevant to maintenance of body homeostasis. By exerting important control of autonomic and endocrine functions, it affects aspects as critical as body temperature, food intake, energy expenditure, water intake, and intermediary metabolism.

Concerning the control of body energy homeostasis, the hypothalamus exerts an integrative influence, as it receives neural, hormonal, and metabolic signals that inform about body energy status. These inputs modify the activity of hypothalamic anabolic and catabolic neurons, whose neuropeptide products stimulate or inhibit food intake, respectively. Disturbances of these control mechanisms have been associated with the pathogenesis of obesity [14].

In this study, we used two-dimensional electrophoresis (2-DE) to separate proteins expressed in the rat hypothalamus. The separated proteins were analysed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS) and the obtained spectra used to determine protein identity.

Proteomic analysis is relatively new in nutrition studies and its potential to contribute to this field has been emphasized [5, 6]. Few studies have used proteomic technology in hypothalamus. It has recently been reported that the hypothalamic expression of Ubiquitin and Ubiquitin carboxyl-terminal esterase L1 (UCHL-1), both components of Ubiquitin-proteasome system, was altered in diet-induced obese rats when compared with diet-resistant rats [7]. Chronic circadian desynchronization in rats led to increased food intake and body weight while affecting expression of five hypothalamic proteins, some of which are involved in carbohydrate metabolism and the Krebs cycle [8]. In another study, estradiol replacement in ovariectomized rats was shown to regulate expression of 29 proteins in ventromedial hypothalamus, some of which are related to neuronal plasticity [9].

The above considerations suggest that proteomic studies of hypothalamic tissue, in the context of nutritional aspects, may provide relevant information not only on physiological control of food intake and energy homeostasis but also on the pathophysiology of obesity and other feeding disturbances. Since the rat hypothalamus is poorly characterized by proteomic strategies, this study focused on identifying proteins expressed in hypothalamus of normal male Wistar rats.

Results and discussion

Reported advantages of protein separation by 2-DE for proteomic analysis include robustness, reproducibility, statistical confidence and ability to separate complete proteins, while sample preparation has been considered a main factor still contributing to variability [10].

In this study, a two-dimensional profile of rat hypothalamus proteins was constructed. Considering that the experimental protocol is a highly relevant aspect in proteomic studies, as it ensures satisfactory resolution and proteome representation [11, 12], experiments were performed aimed at establishing the best conditions for tissue withdrawal and protein extraction, quantification and separation. These results are not shown and we comment on these findings below.

Initially, 5 different extraction buffers were used (Table 1) and the resulting 2-D maps were compared for gel resolution and spot counting. Although all buffers were efficient for hypothalamic protein extraction, the best protein recovery was achieved with buffer 3, regardless the presence of ASB-14 or DTT (data not shown). The presence of both urea and thiourea was probably effective, because this combination has been shown to increase membrane and nuclear proteins solubilisation, even of proteins prone to undergo precipitation during isoelectric focusing [13].
Table 1

Sample preparation procedures and buffers composition

  

1

2

3

3 + DTT

3 + ASB-14

Extraction

Tris–HCl pH 7,6

40 mM

-

-

-

-

Tris

-

20 mM

-

-

-

Urea

-

9 M

7 M

7 M

7 M

Tiourea

-

-

2 M

2 M

2 M

EDTA

-

1 mM

-

-

-

CHAPS (w/v)

2%

4%

4%

4%

4%

Triton X-100 (v/v)

-

-

0.5%

0.5%

0.5%

DTT

-

10 mM

-

100 mM

-

ASB-14 (w/v)

-

-

-

-

2%

Precipitation

 

No

No

Yes

Yes

Yes

Rehydration

Tiourea

2 M

-

 

2 M

 

Urea

7 M

9 M

 

7 M

 

DTT

50 mM

18 mM

 

100 mM

 

CHAPS (w/v)

2%

2%

 

4%

 

Triton x-100 (v/v)

-

-

 

0.5%

 

IPG Buffer pH 3-10 (v/v)

0.5%

2%

 

0.2%

 

Bromofenol blue

traces

traces

 

traces

 

One aspect tested in the present study was the importance of the presence of DTT as reducing agent in the extraction buffer. DTT, which breaks disulfide bonds, has been used in numerous proteomic studies to favour protein solubility in the extraction solution [14]. Indeed, proteome analysis of rat and mice brain regions has used DTT, in concentrations ranging from 10 to 100 mM [8, 9, 1517]. Because we failed to find differences in protein recovery by the addition of 100 mM DTT to buffer 3, it is suggested that the presence of 100 mM DTT in the rehydration buffer was sufficient to efficiently reduce hypothalamic proteins.

The addition of 2% ASB-14 to CHAPS-containing extraction buffer has been shown to improve solubilization of human frontal cortex proteins, when no sample precipitation was performed [18]. In the present experiments with rat hypothalamus, we failed to obtain higher protein recovery by performing precipitation of samples extracted in the presence of ASB-14. We suggest that the precipitation procedure may have interfered with protein recovery extracted in buffer containing ASB-14. Other authors reporting beneficial effects of ASB-14 have also omitted the precipitation step [19, 20].

We chose to include the precipitation step in the present study as this procedure is believed to improve 2-DE quality by eliminating contaminating species (lipids, nucleic acids, and salts), although it may lead to incomplete protein recovery [21, 22]. Among different precipitation methods, chloroform/methanol, as used in the present study, has been recently shown to result in better protein yields from rat hippocampus, amygdala, frontal cortex and striatum [23].

Given all the above considerations, extraction buffer 3 was selected for the proteome characterization of rat hypothalamus. Six extracts from six different four-month-old rats were focused with pH 3–10 strips, in two independent experiments, and the 2-DE gels were analyzed. Each rat sample was analyzed individually, with no tissue pooling. Details of isoelectric focusing and gel separation are given in the Methods section. A high degree of identity among the gels was confirmed by a high scatter plot correlation coefficient (>85%).

Figure 1 shows a representative 2-D gel with molecular weight range from 10 to 250 KDa and pI from 3–9. The number of spots obtained was 234 ± 6, of which 137 were analyzed by mass spectrometry. All analyzed spots were present in all six gels. Table 2 shows the Swiss-Prot Accession Numbers (available at http://www.expasy.ch/sprot), abbreviated and full protein names, theoretical MW and pI values, and mass spectrometry data. Only statistically significant Mascot score results (p < 0.05) were included.
https://static-content.springer.com/image/art%3A10.1186%2F1477-5956-10-26/MediaObjects/12953_2011_Article_367_Fig1_HTML.jpg
Figure 1

Representative 2-D gel of rat hypothalamus stained with Coomassie Blue G-250. The proteins identified are designated with their Swiss-Prot accession numbers. Multiple lines originating from the same Accession Number indicate that the same protein was identified in different spots. Multiple lines originating from the same spot indicate that more than one protein was identified in that spot. Detailed information about the proteins are found in Table 2.

Table 2

Identified proteins from the rat hypothalamus

Name/

Acession

Numbera

Full name

MW (Da)/

pI

Matches/

SCb

PSc

Peptides

ISd

G3P_RAT/P04797

Glyceraldehyde-3-phosphate dehydrogenase

36090/

8.14

4(4)/

17%

274

M.VKVGVNGFGR.I

R.VPTPNVSVVDLTCR.L

K.LISWYDNEYGYSNR.V

K.AENGKLVINGKPITIFQER.D

47

97

92

38

4(2)/

15%

108

M.VKVGVNGFGR.I

R.VPTPNVSVVDLTCR.L

K.LVINGKPITIFQER.D

K.LISWYDNEYGYSNR.V

46

27

16

19

3(2)/

11%

106

M.VKVGVNGFGR.I

R.VPTPNVSVVDLTCR.L

K.LISWYDNEYGYSNR.V

38

19

49

SSDH_RAT/P51650

Succinate-semialdehyde dehydrogenase, mitochondrial

56723/

8.35

1(1)/

1%

44

R.AAYDAFSSWK.E

44

DHE3_RAT/P10860

Glutamate dehydrogenase 1, mitochondrial

61719/

8.05

4(3)/

10%

204

K.MVEGFFDR.G + Oxidation (M)

R.DDGSWEVIEGYR.A

K.HGGTIPVVPTAEFQDR.I

K.IIAEGANGPTTPEADKIFLER.N

17

60

57

70

5(5)/

14%

216

R.DDGSWEVIEGYR.A

K.DIVHSGLAYTMER.S + Oxidation (M)

K.HGGTIPVVPTAEFQDR.I

K.KGFIGPGIDVPAPDMSTGER.E + Oxidation (M)

K.IIAEGANGPTTPEADKIFLER.N

57

41

53

40

27

AK1A1_RAT/P51635

Alcohol dehydrogenase [NADP+]

36711/

6.84

2(0)/

8%

29

R.DAGHPLYPFNDPY.-

R.GLEVTAYSPLGSSDR.A

20

9

CN37_RAT/P13233

2',3'-cyclic-nucleotide 3'-phosphodiesterase

47638/

9.03

4(3)/

7%

169

K.AIFTGYYGK.G

R.ADFSEEYKR.L

K.ATGAEEYAQQDVVR.R

K.ATGAEEYAQQDVVRR.S

51

49

45

23

4(4)/

7%

175

K.AIFTGYYGK.G

R.ADFSEEYKR.L

K.ATGAEEYAQQDVVR.R

K.ATGAEEYAQQDVVRR.S

69

40

36

30

DPYL2_RAT/P47942

Dihydropyrimidinase-related protein 2

62638/

5.95

5(4)/

14%

160

R.KPFPDFVYKR.I

K.IVLEDGTLHVTEGSGR.Y

K.DNFTLIPEGTNGTEER.M

R.NLHQSGFSLSGAQIDDNIPR.R

R.DIGAIAQVHAENGDIIAEEQQR.I

20

31

46

25

39

3(1)/

6%

67

K.VFNLYPR.K

R.KPFPDFVYKR.I

R.ISVGSDADLVIWDPDSVK.T

19

36

12

4(3)/

5%

164

K.VFNLYPR.K

R.KPFPDFVYKR.I

K.THNSALEYNIFEGMECR.G

K.THNSALEYNIFEGMECR.G + Oxidation (M)

37

69

58

(15)

DPYL5_RAT/Q9JHU0

Dihydropyrimidinase-related protein 5

62071/

6.60

4(0)/

7%

45

K.IPHGVSGVQDR.M

R.DSELYQVFHACR.D

R.GRVVYENGVFMCAEGTGK.F

R.GRVVYENGVFM CAEGTGK.F + Oxidation (M)

4

19

(8)

23

UCHL1_RAT/Q00981

Ubiquitin carboxyl-terminal hydrolase isozyme L1

25165/

5.14

4(2)/

22%

157

K.QFLSETEK.L

K.QFLSETEKLSPEDR.A

-.MQLKPMEINPEMLNK.V + 3 Oxidation (M)

R.MPFPVNHGASSEDSLLQDAAK.V + Oxidation (M)

52

82

9

16

2(1)/

15%

52

K.QFLSETEKLSPEDR.A

R.MPFPVNHGASSEDSLLQDAAK.V + Oxidation (M)

38

16

ATPG_RAT/P35435

ATP synthase subunit gamma, mitochondrial

30229/

8.87

2(1)/

8%

73

R.VYGTGSLALYEK.A

R.THSDQFLVSFK.D

63

10

VATE1_RAT/Q6PCU2

V-type proton ATPase subunit E 1

26169/

8.44

4(2)/

14%

102

R.GALFGANANR.K

R.GALFGANANRK.F

K.AEEEFNIEKGR.L

K.IQM SNLM NQAR.L + 2 Oxidation (M)

15

31

45

13

GABT_RAT/P50554

4-aminobutyrate aminotransfe- rase, mitochondrial

57161/

8.15

4(2)/

7%

124

K.TIFMWYR.S

K.VDFEFDYDGPLM K.T + Oxidation (M)

R.GTFCSFDTPDEAIR.N

R.GRGTFCSFDTPDEAIR.N

6

49

52

17

AATC_RAT/P13221

Aspartate aminotransferase cytoplasmic

46628/

6.73

4(4)/

13%

149

R.ITWSNPPAQGAR.I

R.TDDSQPWVLPVVR.K

R.SCASQLVLGDNSPALR.E

R.IVATTLSNPELFKEWK.G

36

40

38

35

NDKB_RAT/P19804

Nucleoside diphosphate kinase B

17386/

6.92

2(0)/

14%

32

K.DRPFFPGLVK.Y

R.TFIAIKPDGVQR.G

12

19

KPYM_RAT/P11980

Pyruvate kinase isozymes M1/M2

58294/

6.63

4(2)/

9%

85

R.LLFEELAR.A

R.YRPRAPIIAVTR.N

K.CLAAALIVLTESGR.S

R.RFDEILEASDGIMVAR.G + Oxidation (M)

43

4

30

10

HXK1_RAT/P05708

Hexokinase-1

103540/

6.29

6(2)/

5%

125

K.EGLLFEGR.I

K.M HPQYSR.R + Oxidation (M)

R.ITPELLTR.G

K.FLSQIESDR.L

R.QIEETLAHFR.L

K.M ISGM YLGEIVR.N + 2 Oxidation (M)

28

17

11

23

53

2

PGK1_RAT/P16617

Phosphoglycerate kinase 1

44909/

8.02

3(2)/

11%

70

K.LGDVYVNDAFGTAHR.A

K.ALESPERPFLAILGGAK.V

K.VLNNMEIGTSLYDEEGAK.I + oxidation (M)

38

6

27

2(2)/

7%

76

K.LGDVYVNDAFGTAHR.A

K.VLNNMEIGTSLYDEEGAK.I + Oxidation (M)

26

50

KCRB_RAT/P07335

Creatine kinase B-type

42983/

5.39

5(4)/

18%

318

R.GFCLPPHCSR.G

K.VLTPELYAELR.A

K.LAVEALSSLDGDLSGR.Y

K.TFLVWINEEDHLR.V

R.GTGGVDTAAVGGVFDVSNADR.L

44

56

67

22

131

2(1)/

5%

52

R.MGGYQPSDEHK.T + oxidation (HW)

K.VLTPELYAELR.A

7

45

KCRU_RAT/P25809

Creatine kinase U-type

47398/

8.72

5(2)/

12%

102

R.GWEFMWNER.L + oxidation (M)

R.LYPPSAEYPDLR.K

R.LYPPSAEYPDLRK.H

R.VVVDALSGLKGDLAGR.Y

K.SFLIWVNEEDHTR.V

19

28

17

11

32

5(3)/

12%

164

R.GWEFMWNER.L + Oxidation (M)

R.LYPPSAEYPDLR.K

R.LYPPSAEYPDLRK.H

K.SFLIWVNEEDHTR.V

R.LGYILTCPSNLGTGLR.A

18

50

17

56

25

ENOG_RAT/P07323

Gamma-enolase

47510/

5.03

5(2)/

14%

98

R.FAGHNFRNPSVL.-

K.M VIGMDVAASEFYR.D + Oxidation (M)

K.M VIGM DVAASEFYR.D + 2 Oxidation (M)

R.AAVPSGASTGIYEALELR.D

K.LAM QEFM ILPVGAESFR.D + 2 Oxidation (M)

18

(6)

17

41

26

ALDOC_RAT/P09117

Fructose-biphosphate aldolase C

39658/

6.67

5(4)/

20%

264

R.ALQASALSAWR.G

R.DNAGAATEEFIKR.A

M.PHSYPALSAEQKK.E

R.CSLPRPWALTFSYGR.A

K.YEGSGDGGAAAQSLYVANHAY.-

59

84

75

8

38

4(1)/

15%

104

K.ELSDIALR.I

R.DNAGAATEEFIKR.A

R.LSQIGVENTEENRR.L

K.YEGSGDGGAAAQSLYVANHAY.-

19

55

24

9

ENOA_RAT/P04764

Alpha-enolase

47440/

6.16

6(4)/

17%

233

R.SFRNPLAK.-

K.LAQSNGWGVMVSHR.S

K.LAQSNGWGVMVSHR.S + Oxidation (M)

R.AAVPSGASTGIYEALELR.D

K.LAMQEFMILPVGASSFR.E + 2 Oxidation (M)

K.AGYTDQVVIGMDVAASEFYR.A + Oxidation (M)

36

(22)

24

99

31

46

2(1)/

8%

60

R.AAVPSGASTGIYEALELR.D

K.AGYTDQVVIGMDVAASEFYR.A + Oxidation (M)

19

41

ALDOA_RAT/P05065

Fructose-biphosphate aldolase A

39783/

8.31

4(2)/

14%

113

M.PHPYPALTPEQK.K

M.PHPYPALTPEQKK.E

K.FSNEEIAMATVTALRR.T + Oxidation (M)

K.YTPSGQSGAAASESLFISNHAY.

40

51

22

6

2(1)/9%

54

M.PHPYPALTPEQKK.E

K.YTPSGQSGAAASESLFISNHAY.

40

17

DCE2_RAT/Q05683

Glutamate decarboxylase 2

66215

/6.45

1(1)/

3%

27

K.LCALLYGDSEKPAESGGSVTSR.A

27

PYGB_RAT/P53534

Glycogen phosphorylase, brain form (fragment)

96854/

6.24

5(1)/

6%

98

R.VIFLENYR.V

R.DYFFALAHTVR.D

R.HLEIIYAYNQR.H

R.VLYPNDNFFEGK.E

K.ARPEYMLPVHFYGR.V + oxidation (HW)

5

25

44

22

8

TPIS_RAT/P48500

Triosephosphate isomerase

27345/

6.89

4(3)/

14%

115

K.FFVGGNWK.M

R.KFFVGGNWK.M

R.IIYGGSVTGATCK.E

K.DLGATWVVLGHSER.R

45

8

29

32

5(2)/

20%

147

K.FFVGGNWK.M

R.KFFVGGNWK.M

R.IIYGGSVTGATCK.E

K.DLGATWVVLGHSER.R

R.RHIFGESDELIGQK.V

49

14

59

10

15

GLNA_RAT/P09606

Glutamine synthetase

42982/

6.64

5(2)/

16%

133

K.RHQYHIR.A

K.IQLM YIWVDGTGEGLR.C + Oxidation (M)

R.RPSANCDPYAVTEAIVR.T

R.LTGFHETSNINDFSAGVANR.S

R.RLTGFHETSNINDFSAGVANR.S

24

43

19

40

10

CALR_RAT/P18418

Calreticulin

48137/

4.33

3(2)/

9%

197

K.EQFLDGDAWTNR.W

K.HEQNIDCGGGYVK.L

K.IKDPDAAKPEDWDER.A

102

13

82

SCRN1_RAT/Q6AY84

Secernin-1

46994/

4.73

2(2)/

7%

88

K.VECTYISIDQVPR.T

R.SSPCIHYFTGTPDPSR.S

49

39

IMPCT_RAT/Q5GFD9

Protein IMPACT

36314/

5.07

2(1)/

10%

37

K.SLEEIYMK.N + Oxidation (M)

K.ISESAPEAEELPPIAHGAPITDRR.S

2

35

PGAM1_RAT/P25113

Phosphoglycerate mutase 1

28928/

6.67

3(2)/

18%

121

R.HGESAWNLENR.F

R.ALPFWNEEIVPQIK.E

R.SYDVPPPPM EPDHPFYSNISK.D + Oxidation (M)

59

44

21

VDAC1_RAT/Q9Z2L0

Voltage-dependent anion-selective channel protein 1

30851/

8.62

3(1)/

8%

66

R.WTEYGLTFTEK.W

K.YQVDPDACFSAK.V

K.YRWTEYGLTFTEK.W

40

16

12

3(1)/

12%

86

R.VTQSNFAVGYK.T

R.WTEYGLTFTEK.W

K.YQVDPDACFSAK.V

13

24

51

VDAC2_RAT/P81155

Voltage-dependent anion- selective channel protein 2

32353/

7.44

3(2)/

17%

121

R.SNFAVGYR.T

K.VNNSSLIGVGYTQTLRPGVK.L

R.TGDFQLHTNVNNGTEFGGSIYQK.V

41

71

9

ALBU_RAT/P02770

Serum albumin

70682/

6.09

3(2)/

7%

83

K.LGEYGFQNAVLVR.Y

K.LRDNYGELADCCAK.Q

K.AADKDNCFATEGPNLVAR.S

35

19

29

NSF_RAT/Q9QUL6

Vesicle-fusing ATPase

83170/

6.55

3(0)/

4%

40

K.GILLYGPPGCGK.T

K.NFSGAELEGLVR.A

R.QSIINPDWNFEK.M

25

6

12

EF1G_RAT/Q68FR6

Elongation factor 1-gamma

50371/

6.31

2(0)/

4%

38

K.AKDPFAHLPK.S

K.STFVLDEFKR.K

14

24

1433G_RAT/P61983

14-3-3 protein gamma

28456/

4.80

1(1)/

5%

88

K.NVTELNEPLSNEER.N

88

1433E_RAT/P62260

14-3-3 protein épsilon

29326/

4.63

3(3)/

9%

142

R.YLAEFATGNDR.K

R.YLAEFATGNDRK.E

K.VAGM DVELTVEER.N + Oxidation (M)

36

77

29

1433B_RAT/P35213

14-3-3 protein beta/alpha

28151/

4.81

3(0)/

13%

48

R.NLLSVAYK.N

K.DSTLIM QLLR.D + Oxidation (M)

K.AVTEQGHELSNEER.N

16

15

18

1433Z_RAT/P63102

14-3-3 protein zeta/delta

27925/

4.73

3(2)/

16%

148

R.NLLSVAYK.N

K.SVTEQGAELSNEER.N

K.GIVDQSQQAYQEAFEISK.K

25

92

31

1433T_RAT/P68255

14-3-3 protein theta

28046/

4.69

2(1)/

8%

76

R.NLLSVAYK.N

K.AVTEQGAELSNEER.N

25

51

PEBP1_RAT/P31044

Phosphatidylethanolamine- binding protein 1

20902/

5.48

3(2)/

22%

149

K.FKVESFR.K

R.VDYGGVTVDELGK.V

K.YHLGAPVAGTCFQAEWDDSVPK.L

39

92

18

EF2_RAT/P05197

Elongation factor 2

96192/

6.41

3(1)/

5%

74

M.VNFTVDQIR.A

K.AYLPVNESFGFTADLR.S

K.ARPFPDGLAEDIDKGEVSAR.Q

42

21

11

GNAO_RAT/P59215

Guanine nucleotide-binding protein G(o) subunit alpha

40613/

5.34

5(2)/

15%

114

K.YYLDSLDR.I

R.AMDTLGVEYGDKER.K + Oxidation (M)

R.IGAADYQPTEQDILR.T

R.MEDTEPFSAELLSAMMR.L + 2 Oxidation (M)

R.MEDTEPFSAELLSAMMR.L + 3 Oxidation (M)

17

29

59

(5)

8

3(1)/

12%

66

R.AMDTLGVEYGDKER.K + Oxidation (M)

R.IGAADYQPTEQDILR.T

R.MEDTEPFSAELLSAMMR.L + 3 Oxidation (M)

18

45

3

GBB1_RAT/P54311

Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1

38151/

5.60

3(2)/

7%

76

K.IYAMHWGTDSR.L

K.IYAMHWGTDSR.L + Oxidation (M)

R.ELAGHTGYLSCCR.F

43

(18)

33

GDIA_RAT/P50398

Rab GDP dissociation inhibitor alpha

51074/

5.00

5(4)/

16%

195

R.IKLYSESLAR.Y

R.GRDWNVDLIPK.F

R.FQLLEGPPESMGR.G + Oxidation (M)

K.SPYLYPLYGLGELPQGFAR.L

R.NPYYGGESSSITPLEELYKR.F

22

64

41

26

45

MK01_RAT/P63086

Mitogen-activated protein kinase 1

41648/

6.50

4(0)/

8%

79

R.GQVFDVGPR.Y

K.ELIFEETAR.F

K.LKELIFEETAR.F

K.ISPFEHQTYCQR.T

25

21

23

10

STXB1_RAT/P61765

Syntaxin-binding protein 1

67925/

6.49

2(1)/

3%

41

R.SQLLILDR.G

R.ISEQTYQLSR.W

13

30

ANXA5_RAT/P14668

Annexin A5

35779/

4.93

3(1)/

11%

80

K.VLTEIIASR.T

R.GTVTDFSGFDGR.A

K.GLGTDEDSILNLLTAR.S

22

37

21

TBB2A_RAT/P85108

Tubulin beta-2A chain

50274/

4.78

4(3)/

9%

137

R.LHFFMPGFAPLTSR.G

R.LHFFMPGFAPLTSR.G + oxidation (M)

K.NSSYFVEWIPNNVK.T

R.INVYYNEATGGKYVPR.A

46

(11)

57

34

TBB2C_RAT/Q6P9T8

Tubulin beta-2C chain

50225/

4.79

5(4)/

11%

188

R.YLTVAAVFR.G

R.LHFFMPGFAPLTSR.G

R.LHFFMPGFAPLTSR.G + oxidation (M)

K.NSSYFVEWIPNNVK.T

R.INVYYNEATGGKYVPR.A

55

46

(11)

57

30

TBB3_RAT/Q4QRB4

Tubulin beta-3 chain

50842/

4.82

2(1)/

6%

72

R.LHFFMPGFAPLTAR.G + oxidation (M)

K.NSSYFVEWIPNNVK.V

18

57

TBA1A_RAT/P68370

Tubulin alpha-1A chain

50788/

4.94

4(4)/

13%

246

R.QLFHPEQLITGK.E

R.AVFVDLEPTVIDEVR.T

R.IHFPLATYAPVISAEK.A

R.AVCMLSNTTAIAEAWAR.L

32

100

67

47

TBA1C_RAT/Q6AYZ1

Tubulin alpha-1C chain

50590/

4.96

4(4)/

13%

246

R.QLFHPEQLITGK.E

R.AVFVDLEPTVIDEVR.T

R.IHFPLATYAPVISAEK.A

R.AVCMLSNTTAIAEAWAR.L

32

100

67

47

TBA1B_RAT/Q6P9V9

Tubulin alpha-1B chain

50804/

4.94

4(4)/

13%

246

R.QLFHPEQLITGK.E

R.AVFVDLEPTVIDEVR.T

R.IHFPLATYAPVISAEK.A

R.AVCMLSNTTAIAEAWAR.L

32

100

67

47

TBA4A_RAT/Q5XIF6

Tubulin alpha-4A chain

50634/

4.95

4(4)/

13%

185

R.QLFHPEQLITGK.E

R.AVFVDLEPTVIDEIR.N

R.IHFPLATYAPVISAEK.A

R.AVCMLSNTTAIAEAWAR.L

32

41

67

47

ACTB_RAT/P60711

Actin, cytoplasmic 1

42052/

5.29

5(4)/

20%

235

R.AVFPSIVGRPR.H

K.IWHHTFYNELR.V

K.SYELPDGQVITIGNER.F

R.VAPEEHPVLLTEAPLNPK.A

K.DLYANTVLSGGTTMYPGIADR.M + Oxidation (M)

35

62

78

49

13

MDHM_RAT/P04636

Malate dehydrogenase, mitochondrial

36117/

8.93

1(1)/

4%

33

K.AGAGSATLSMAYAGAR.F + Oxidation (M)

33

ROA2_RAT/A7VJC2

Heterogeneous nuclear ribonucleoproteins A2/B1

37512/

8.97

3(2)/

10%

86

R.GGNFGFGDSR.G

R.GGGGNFGPGPGSNFR.G

K.YHTINGHNAEVR.K

30

32

24

COF1_RAT/P45592

Cofilin-1

18749/

8.22

2(1)/

16%

107

R.YALYDATYETK.E

K.LTGIKHELQANCYEEVK.D

90

17

DYN1_RAT/P21575

Dynamin-1

97576/

6.44

2(1)/

2%

51

K.FTDFEEVR.L

K.VLNQQLTNHIR.D

26

25

NFL_RAT/P19527

Neurofilament light polypeptide

61355/

4.63

5(4)/

13%

195

R.ALYEQEIR.D

R.YLKEYQDLLNVK.M

R.SAYSGLQSSSYLMSAR.A + Oxidation (M)

R.SAYSSYSAPVSSSLSVR.R

R.LSFTSVGSITSGYSQSSQVFGR.S

40

64

44

23

27

NFM_RAT/P12839

Neurofilament medium polypeptide

95848/

4.77

2(2)/

3%

83

K.VQSLQDEVAFLR.S

R.FSTFSGSITGPLYTHR.Q

55

27

PRDX1_RAT/Q63716

Peroxiredoxin-1

22323/

8.27

4(2)/

20%

133

K.IGHPAPSFK.A

R.TIAQDYGVLK.A

R.LVQAFQFTDK.H

R.QITINDLPVGR.S

50

20

39

23

PRDX2_RAT/P35704

Peroxiredoxin-2

21941/

5.34

1(1)/

9%

25

K.SLSQNYGVLKNDEGIAYR.G

25

SODM_RAT/P07895

Superoxide dismutase [Mn], mitochondrial

24887/

8.96

2(1)/

13%

87

K.AIWNVINWENVSQR.Y

K.HHATYVNNLNVTEEK.Y

3

84

GSTP1_RAT/P04906

Glutathione S-transferase P

23652/

6.89

2(1)/

13%

47

M.PPYTIVYFPVR.G

K.YGTLIYTNYENGKDDYVK.A

47

0

GRP78_RAT/P06761

78 kDa glucose-regulated protein

72473/

5.07

1(1)/

2%

29

K.VTHAVVTVPAYFNDAQR.Q

29

HS90A_RAT/

P82995

Heat shock protein HSP 90-alpha

85161/

4.93

5(1)/

7%

79

R.RAPFDLFENR.K

R.GVVDSEDLPLNISR.E

K.HLEINPDHSIIETLR.Q

R.NPDDITNEEYGEFYK.S

K.KHLEINPDHSIIETLR.Q

15

15

9

10

29

HS90B_RAT/

P34058

Heat shock protein HSP 90-beta

83571/

4,97

2(0)/

4%

26

R.GVVDSEDLPLNISR.E

R.NPDDITQEEYGEFYK.S

15

11

HSP7C_RAT/P63018

Heat shock cognate 71 kDa protein

71055/

5.37

4(2)/

9%

114

K.DAGTIAGLNVLR.I

R.TTPSYVAFTDTER.L

K.NQVAMNPTNTVFDAKR.L + Oxidation (M)

K.TVTNAVVTVPAYFNDSQR.Q

9

66

10

28

ENPL_RAT/Q66HD0

Endoplasmin

92998/

4.72

4(2)/

5%

103

R.GLFDEYGSK.K

K.FAFQAEVNR.M

K.SILFVPTSAPR.G

R.FQSSHHSTDITSLDQYVER.M

45

23

30

7

PPIA_RAT/P10111

Peptidyl-prolyl cis-trans isomerase A

18091/

8.34

4(0)/

27%

81

K.FEDENFILK.H

K.GFGYKGSSFHR.I

R.VCFELFADKVPK.T

K.TEWLDGKHVVFGK.V

23

23

15

20

5(5)/

38%

224

K.FEDENFILK.H

K.GFGYKGSSFHR.I

R.VCFELFADKVPK.T

K.TEWLDGKHVVFGK.V

M.VNPTVFFDITADGEPLGR.V

45

54

44

38

48

LDHA_RAT/P04642

L-lactate dehydrogenase A chain

18749/

8.22

4(2)/

11%

105

K.LVIITAGAR.Q

R.FRYLM GER.L + Oxidation (M)e

K.SADTLWGIQK.E

K.VTLTPDEEAR.L

30

23

35

17

LDHB_RAT/P42123

L-lactate dehydrogenase B chain

36874/

5.70

3(2)/

8%

121

K.IVVVTAGVR.Q

R.GLTSVINQK.L

K.SADTLWDIQK.D

23

31

67

MDHC_RAT/O88989

Malate dehydrogenase, cytoplasmic

36631/

6.16

4(2)/

15%

105

K.GEFITTVQQR.G

K.FVEGLPINDFSR.E

K.SAPSIPKENFSCLTR.L

K.EVGVYEALKDDSWLK.G

37

36

14

18

NDUS2_RAT/Q641Y2

NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial

52927/

6.52

2(1)/

7%

56

K.GEFGVYLVSDGSSRPYR.C

K.TQPYDVYDQVEFDVPIGSR.G

33

23

DLDH_RAT/Q6P6R2

Dihydrolipoyl dehydrogenase, mitochondrial

54574/

7.96

3(2)/

6%

73

R.GIEIPEVR.L

K.VGKFPFAANSR.A

R.VCHAHPTLSEAFR.E

12

37

27

DHE3_RAT/P10860

Glutamate dehydrogenase 1, mitochondrial

61719/

8.05

1(1)/

2%

32

R.DDGSWEVIEGYR.A

32

ATPA_RAT/P15999

ATP synthase subunit alpha, mitochondrial

59831/

9.22

4(4)/

9%

226

R.VGLKAPGIIPR.I

K.LYCIYVAIGQKR.S

R.EAYPGDVFYLRSR.L

R.TGAIVDVPVGDELLGR.V

41

33

80

71

4(2)/

8%

100

R.VLSIGDGIAR.V

K.AVDSLVPIGR.G

R.EAYPGDVFYLHSR.L

R.ILGADTSVDLEETGR.V

16

33

32

19

QCR1_RAT/Q68FY0

Cytochrome b-c1 complex subunit 1

53500/

5.57

2(2)/

5%

118

R.RIPLAEWESR.I

K.EVESIGAHLNAYSTR.E

39

81

QCR2_RAT/P32551

Cytochrome b-c1 complex subunit 2, mitochondrial

48423/

9.16

3(1)/

7%

72

K.AVAFQNPQTR.I

K.EVAEQFLNIR.G

K.NALANPLYCPDYR.M

21

21

30

ACON_RAT/Q9ER34

Aconitate hydratase mitochondrial

86121/

7.87

6(6)/

9%

300

R.DGYAQILR.D

K.EGWFLDIR.V

K.SQFTITPGSEQIR.A

K.VAMSHFEPSEYIR.Y + oxidation (M)

R.NAVTQEFGPVPDTAR.Y

R.WVVIGDENYGEGSSR.E

49

48

37

42

51

75

6(4)/

9%

175

K.EGWPLDIR.V

R.HLGGRAIITK.S

K.VAMSHFEPSEYIR.Y + Oxidation (M)

 R.NAVTQEFGPVPDTAR.Y

R.WVVIGDENYGEGSSR.E

K.IVYGHLDDPANQEIER.G

33

9

43

44

43

5

EFTU_RAT/P85834

Elongation factor Tu, mitochondrial

49890/

7.23

1(1)/

3%

54

R.GITINAAHVEYSTAAR.H

54

SPTA2_RAT/P16086

Spectrin alpha chain

285261/

5.20

3(0)/

1%

44

R.EELITNWEQIR.T

R.ELPTAFDYVEFTR.S

K.HQAFEAELHANADR.I

25

21

6

ACTZ_RAT/P85515

Alpha-centractin

42701/

6.19

1(1)/

2%

43

K.YCFPNYVGRPK.H

43

SNAB_RAT/P85969

Beta-soluble NSF attachment protein

33791/

5.32

2(2)/

8%

118

K.VAAYAAQLEQYQK.A

K.YEEMFPAFTDSR.E + Oxidation (M)

79

39

TKT_RAT/P50137

Transketolase

68342/

7.23

3(1)/

8%

67

R.TVPFCSTFAAFFTR.A

K.ILATPPQEDAPSVDIANIR.M

R.TSRPENAIIYSNNEDFQVGQAK.V

33

24

10

aAccession number of Swiss-Prot database.

bSequence coverage.

cProtein score: protein overall scores higher than 25 are significant (P < 0.05).

dIon score.

Importantly, all protein assignments listed in this study had a false discovery rate (FDR) of 0%, as estimated by decoy database analysis provided by Mascot. Because FDR is a source of error in protein identification, its estimation is important to validate data. Searches against a composite target-decoy database have been shown to provide an effective way of FDR estimation [24].

The analysis led to the identification of 86 different proteins contained in 97 spots. Figure 1 shows that there were 57 spots in which only one protein was identified. In six spots, 2, 3, or 4 proteins were identified. In four cases, proteins were highly homologous (subtypes of tubulin alpha and beta chains; 14-3-3 protein zeta/delta and theta; heat shock protein HSP 90 alpha and beta) while in two cases, 2 proteins constituting the same spot were not related (heterogeneous nuclear ribonucleoproteins A2/B1 and malate dehydrogenase mitochondrial; glutamate dehydrogenase 1 and dihydrolipoyl dehydrogenase). The fact that their molecular masses and isoelectric points are very similar suggests the occurrence of protein overlapping. It is important to point out that we found 60% of the spots to comprise a single polypeptide chain, agreeing with the analysis of overlapping as a function of protein load [25].

Additional experiments were performed using isoelectric focusing with pH 4–7 strips with the objective of better resolving spots presenting multiple proteins. In the 6 gels performed, 141 ± 1 spots were resolved, of which 50 were cut and digested. The analysis led to the identification of 38 proteins, whose identity confirmed the results obtained with the broad-range strip (data not shown). These findings demonstrate that the use of pH 3–10 IEF strips is appropriate for proteomic studies of rat hypothalamus.

Finally, 17 proteins were identified in more than one spot, for example, the enzymes fructose-bisphosphate aldolase C (P09117, 2 spots), glyceraldehyde-3-phosphate dehydrogenase (P04797, 3 spots), and dihydropyrimidinase-related protein 2 (P47942, 3 spots). The presence of one protein in multiple spots has been suggested to reflect isoforms or post-translational modifications. Creatine kinase B-type (P07335), an enzyme that plays a role in cell energy metabolism, is represented in two spots differing in isoelectric points. This enzyme is also present in different spots of 2-D gels of crude microtubule preparations from rat brains, the isoelectric variants corresponding to a phosphorylated and a non-phosphorylated form [26].

In order to confirm protein identification, we performed one additional experiment using Western blot for the protein glyceraldehyde-3-phosphate dehydrogenase. Figure 2, showing high binding of the specific antibody to the three analysed spots indicate the accuracy of the protein identification in the present study.
https://static-content.springer.com/image/art%3A10.1186%2F1477-5956-10-26/MediaObjects/12953_2011_Article_367_Fig2_HTML.jpg
Figure 2

Western blot confirmation of protein identity. 2-D gel of rat hypothalamus stained with Coomassie Blue G-250 (a). Immunobloting of glyceraldehyde-3-phosphate dehydrogenase (b).

Approximately 75% of the identified proteins had molecular masses in the 30–100 KDa range and 79% had pI values between 4 and 8. Thus, we were able to identify only four low molecular weight proteins (under 20 kDa) (l-lactate dehydrogenase A chain, P04642; nucleoside diphosphate kinase B, P19804; cofilin-1, P45592; peptidyl-prolyl cis-trans isomerase A, P10111) and only one protein with a molecular weight above 150 kDa (spectrin alpha-chain, P16086). This agrees with the low ability of 2-DE protein separation to resolve proteins in upper and lower limits of molecular mass range [27].

The Swiss-Prot database was used to classify proteins according to their subcellular location and, as expected, most of the identified proteins are cytoplasmatic, as shown in Figure 3a. Although both the chaotropic agent thiourea and the zwitterionic detergent CHAPS were used in the extraction buffer to maximize membrane protein solubility [20], only 10% of the identified proteins were membrane proteins. This low recovery has been associated with the poor solubilization of hydrophobic molecules in 2-DE technique [28, 29].
https://static-content.springer.com/image/art%3A10.1186%2F1477-5956-10-26/MediaObjects/12953_2011_Article_367_Fig3_HTML.jpg
Figure 3

Protein Ontology. Identified proteins were classified according to their subcellular location (a), biological processes (b), molecular function (c), and protein class (d).

Gene Ontology analysis of identified proteins was performed using the bioinformatics tool PANTHER [30] (http://www.pantherdb.org/). In this way, proteins were categorized according to biological processes (Figure 3b), molecular function (Figure 3c) and protein class (Figure 3d). An additional file shows the classification of each protein in more detail (see Additional file 1).

The majority of the identified proteins were classified as participating in metabolic processes (Figure 3b), consistent with the finding of a large number of proteins with catalytic activity (Figure 3c). Oxidoreductases, transferases, and hydrolases were the main protein classes identified in this study (Figure 3d).

Genes encoding some proteins identified in this study have been related to obesity development. When gene expression profile was performed in obese subjects, genes involved in NADH dehydrogenase (ubiquinone) activity, glutamate dehydrogenase activity and glutamate decarboxylase activity, among others, were up-regulated in comparison to normal lean individuals [31].

GAD2 polymorphisms are believed to be associated with disrupted eating behavior and obesity risk in women [32]. The GAD2 gene encodes the enzyme glutamate decarboxylase 2 (Q05683), which catalyzes glutamate decarboxylation to γ-aminobutyric acid (GABA). According to the authors, GAD2 polymorphisms could modulate increases in hypothalamic GABA concentration, enhancing the orexigenic effect of neuropeptide Y (NPY). Moreover, GAD2 has been suggested to participate in complex polygenic mechanisms linking birth weight to further risk for metabolic diseases [33].

Excessive superoxide production has been related to obesity and several other chronic diseases. An association between obesity and manganese-dependent superoxide dismutase gene polymorphism has been reported in elderly subjects. A possible biological explanation of this association could be a chronic state of superoxide enzyme (P07895) imbalance present in subject carriers of gene polymorphism, which could affect differential metabolic pathways contributing to obesity development [34].

With the use of proteomic approach in rat hypothalamic tissue, it has recently been reported that perinatal undernutrition modulated numerous metabolic pathways, resulting in alterations of hypothalamic energy supply. In the 12–16 day-old male offspring, proteins related to energy-sensing, redox status, amino acid pathways and neurodevelopment, including fructose bisphosphate aldolase C (P09117), malate dehydrogenase cytoplasmic (O88989), and dihydropyrimidinase related protein 2 (P47942) were affected [35]. We have previously shown that female adult rats exposed to intrauterine food restriction had obesity and defects in hypothalamic systems involved in feeding regulation [36, 37]. Importantly, we are currently applying the present protocol of hypothalamic proteomic analysis to further characterize the late consequences of intrauterine food restriction.

In another study in the nutrition field, cows subjected to energy restriction for 60 hours showed altered expression of nine hypothalamic proteins that are potential candidate molecules involved in maintaining energy homeostasis, such as ubiquitin carboxyl-terminal hydrolase L1 (Q00981) [38]. Furthermore, chronic circadian desynchronization has led to increased food intake, weight gain and fat mass in rats, and affected the expression of five hypothalamic proteins: fructose-bisphosphate aldolase A (P05065), aconitase 2, GABA aminotransferase, aldehyde dehydrogenase family 1 member B1 and VDAC1 (Q9Z2L0) [8].

Conclusion

In summary, the methods described herein allowed identification of 86 hypothalamic proteins, some of which have already been found to be altered in obesity. There have been relatively few analyses of hypothalamic proteomes of male Wistar rats and the current identification contributes to the building of a database for this important neuroendocrine structure. These results will serve as a reference database for studies testing the effects of dietary manipulations on hypothalamic proteome. We trust that these experiments will lead to important knowledge on protein targets of nutritional variables potentially able to affect the complex central nervous system control of energy homeostasis.

Methods

Animals and sample preparation

All procedures were in compliance with guidelines of Committee on Research Ethics of Federal University of São Paulo. Male Wistar were kept under controlled conditions of temperature and lighting (lights on from 6:00 to 18:00 h). Four- month-old rats were killed by decapitation, the skull was rapidly opened and the hypothalami removed and immediately homogenized in 1 mL of extraction buffer. The hypothalamus was dissected having the thalamus as the dorsal limit, with the rostral and caudal limits being the optic chiasm and the mammillary bodies, respectively [39].

In order to determine the optimal conditions for proteome analysis of rat hypothalamus, a series of tests were performed.2-D gels of samples prepared with five different extraction and rehydration buffers were analysed for spot counting and resolution. All buffers contained complete Mini Protease Inhibitor Cocktail Tablets (Roche Diagnostics, Germany), added immediately before use. Each rat sample was analyzed individually, with no tissue pooling. After sample homogenization, lysates were centrifuged at 14.000 rpm for 30 minutes; supernatants were collected and stored at - 80°C until use. Table 1 summarizes buffers composition and the procedures used for sample preparation.

Protein assay

Protein concentration of supernatants was determined using 2-D Quant Kit (GE Healthcare, USA) and bovine albumin as standard, according to manufacturer's recommendations. Protein concentrations were typically between 3 and 4.5 mg/mL.

Protein precipitation

Aliquots of 750 μg of protein were precipitated with a solution of 35% KCl, 44% chloroform, and 21% methanol (v/v). The mixture was homogenized by vortex mixing and centrifuged at 14.000 rpm and 4°C for 15 min. The pellet was recovered and air-dried.

Two-dimensional gel electrophoresis and image analysis

For isoelectric focusing (IEF), the pellet was dissolved in 500 μL of rehydration buffer. When protein precipitation was not performed (buffers 1 and 2, please see Table 1), the rehydration solution was added to the sample, to a final volume of 500μL. IEF was carried out on a Protean IEF cell (Bio-Rad, USA) using immobiline dry strips (18 cm linear gradient, pH 3–10 and pH 4–7) previously rehydrated for 12-14 h. IEF was performed with the current limit set at 50 mA per IPG strip with the following conditions at 18°C: 1000 V for 30 minutes, 2000 V for 1 hour, 4000 V for 1 hour, 8000 V for one hour, 8000 V until 40000 Vh.

After focusing, strips were equilibrated for 15 min in buffer containing 6 M urea, 50 mM Tris base pH 8.8, 34% (v/v) glycerol, 2% (w/v) SDS (Sodium Dodecyl Sulfate), and 1% (w/v) DDT, followed by an additional 15 min in the same buffer containing 2.5% (w/v) iodocetamide instead of DTT. Strips were then loaded onto 12% SDS-polyacrylamide gels. After running in Protean II Multi-Cell (Bio-Rad, USA), at 50 mA per gel for 5 hours, the gels were stained for 48 h with Coomassie Blue G-250 (Bio-Rad, USA). Stained gels were scanned (GS-710 Calibrated Imaging Densitometer) and analyzed using PDQuest Image Analysis Software version 7.2 (Bio-Rad, USA).

To construct a two-dimensional gel electrophoresis profile of rat hypothalamus proteins, six different rats were used and each hypothalamus was analysed separately, in two independent experiments. Each analyzed spot was present in all six gels.

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry

The selected spots were automatically excised, destained and digested, using XciseTM spot picker (Shimadzu Biotech, Japan), as reported elsewhere [40]. Briefly, excised spots were destained in 100 mM ammonium bicarbonate and 50% acetonitrile (1:1) and digestion was performed in 30 μL of 10 ng/μL trypsin (Sigma Aldrich, Germany) in 25 mM ammonium bicarbonate, overnight at 34°C. Digested samples were desalted using μC18 Zip Tips (Millipore, Ireland). One microliter of sample was mixed with matrix solution (10 mg/mL α-cyano-4 hydroxycinnamic acid in 70% acetonitrile/0.1% trifluoroacetic acid), applied on the spectrometer plate and air dried at room temperature.

MALDI-TOF/TOF MS was performed using an Axima Performance ToF-ToF, (Kratos-Shimadzu Biotech, UK) mass spectrometer. The instrument was externally calibrated with [M + H]+ ions of bradykinin 1–7 fragment (757.4 Da), human angiotensin II (1046.54 Da), P14R synthetic peptide (1533.86 Da), and human ACTH 18–39 fragment (2465.20 Da). Following MALDI MS analysis, MALDI MS/MS was performed on 7 most abundant ions from each spot.

MASCOT (Matrix Science, UK) server was used to search Swiss-Prot protein database (http://www.expasy.ch/sprot/). The following parameters were used in this search: no restrictions on protein molecular weight, trypsin digest with one missing cleavage, monoisotopic mass, taxonomy limited to Rattus, carbamidomethylation of cysteine as fixed modification, possible oxidation of methionine and tryptophan, peptide mass tolerance of 0.5 Da, fragment mass tolerance of 0.8 Da, and peptide charge +1. False discovery rate (FDR) assessment was estimated using Mascot decoy database approach and only proteins identified with 0% FDR were included in the results.

Protein matching probabilities were determined using MASCOT protein scores, with identification confidence indicated by the number of matching and the coverage of protein sequence by the matching peptides. The presence of at least one peptide with significant ion score was required for positive protein identification. Only statistically significant MASCOT score results (p < 0.05) were included in the analysis.

Western blot procedures

For confirmation of protein identity, two 2-D gels were performed in identical conditions as those described above, with protein extracted from one rat hypothalamus. One of the gels was stained with Coomassie Blue G-250 while the other was cut and had its proteins transferred to a nitrocellulose membrane, as previously described [41]. After blockage, the membrane was incubated with glyceraldehyde-3-phosphate dehydrogenase antibody (GAPDH, sc-25778, Santa Cruz Biotechnology, USA) followed by secondary anti-rabbit antibody and revealed by chemiluminescense.

Declarations

Acknowledgments

This research was supported by grants from the Brazilian agencies: State of São Paulo Research Foundation (FAPESP), National Council for Scientific and Technological Development (CNPq), and Coordination for the Enhancement of Higher Education Personnel (CAPES).

The authors are indebted to Dr Ricardo Bertolla for his assistance in analysing decoy data.

Authors’ Affiliations

(1)
Department of Physiology, Division of Nutrition Physiology, Universidade Federal de São Paulo, UNIFESP
(2)
Department of Biological Sciences, Universidade Federal de São Paulo, UNIFESP
(3)
Department of Medicine, Division of Nephrology, Universidade Federal de São Paulo, UNIFESP
(4)
Department of Microbiology, Immunology and Parasitology, Universidade Federal de São Paulo, UNIFESP
(5)
Centro de Química de Proteínas, FMRP, Universidade de São Paulo
(6)
Departamento de Fisiologia, Universidade Federal de São Paulo – Escola Paulista de Medicina

References

  1. Flier JS: Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004, 116: 337–350. 10.1016/S0092-8674(03)01081-XView ArticlePubMed
  2. Ribeiro EB, Telles MM, Oyama LM, Silveira VLF, Nascimento CMO: Hypothalamic serotonin in the control of food intake: physiological interactions and effect of obesity. In Focus on Nutrition Research. Edited by: Starks TP. Nova Science Publishers, New York; 2006:121–148.
  3. López M, Tovar S, Vázquez MJ, Williams LM, Diéguez C: Peripheral tissue-brain interactions in the regulation of food intake. Proc Nutr Soc 2007, 66: 131–155. 10.1017/S0029665107005368View ArticlePubMed
  4. Ribeiro EB: Studying the central control of food intake and obesity in rats. Rev Nutr 2009,22(1):163–171. 10.1590/S1415-52732009000100015View Article
  5. Wang J, Li D, Dangott LJ, Wu G: Proteomics and its role in nutrition research. J Nutr 2006, 136: 1759–1762.PubMed
  6. Schweigert FJ: Nutritional proteomics: methods and concepts in nutritional science. Ann Nutr Metab 2007, 51: 99–107. 10.1159/000102101View ArticlePubMed
  7. Wang Q, Yang H, Tian D, Cai Y, Wei Z, Wang F, Yu AC, Han J: Proteomic analysis of rat hypothalamus revealed the role of Ubiquitin-proteasome system in the Genesis of DR or DIO. Neurochem Res 2011, 36: 939–946. 10.1007/s11064-011-0423-4View ArticlePubMed
  8. Mishra A, Cheng C, Lee W, Tsai L: Proteomic changes in the hypothalamus and retroperitoneal fat from male F344 rats subjected to repeated light–dark shifts. Proteomics 2009, 9: 1–12. 10.1002/pmic.200890093View Article
  9. Mo B, Callegari E, Telefont M, Renner KJ: Estrogen regulation of proteins in the rat ventromedial nucleus of the hypothalamus. J Proteome Res 2008, 7: 5040–5048. 10.1021/pr8005974View ArticlePubMed
  10. Rabilloud T, Chevallet M, Luche S, Lelong C: Two-dimensional gel electrophoresis in proteomics: past, present and future. J Proteomics 2010, 73: 2064–2077. 10.1016/j.jprot.2010.05.016View ArticlePubMed
  11. Carboni L, Piubelli C, Righetti PG, Jansson B, Domenici E: Proteomic analysis of rat brain tissue: comparison of protocols for two-dimensional gel electrophoresis analysis based on different solubilizing agents. Electrophoresis 2002, 23: 4132–4141. 10.1002/elps.200290031View ArticlePubMed
  12. Hirano M, Rakwal R, Shibato J, Agrawal GK, Jwa N, Iwahashi H, Masuo Y: New protein extraction/solubilization protocol for gel-based proteomics of rat (female) whole brain and brain regions. Mol Cells 2006, 22: 119–125.PubMed
  13. Rabilloud T, Adessi C, Giraudel A, Lunardi J: Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1997, 18: 307–316. 10.1002/elps.1150180303View ArticlePubMed
  14. Cleland WW: Dithiothreitol, a new protective reagent for SH groups. Biochemestry 1964,3(4):480–482. 10.1021/bi00892a002View Article
  15. Beranova-Giorgianni S, Pabst MJ, Russel TM, Giorgianni F, Goldowitz D, Desiderio DM: Preliminary analysis of the mouse cerebellum proteome. Mol Brain Res 2002, 98: 135–140. 10.1016/S0169-328X(01)00333-3View ArticlePubMed
  16. Li X, Wang H, Oiu P, Luo H: Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain. Neurochem Int 2008, 52: 256–264. 10.1016/j.neuint.2007.06.014View ArticlePubMed
  17. Paskulin R, Jamnik P, Zivin M, Raspor P, Strukelj B: Ibogaine affects brain energy metabolism. Eur J Pharmacol 2006, 552: 11–14. 10.1016/j.ejphar.2006.09.008View ArticlePubMed
  18. Martins-de-Souza D, Oliveira BM, Farias AS, Horiuchi RSO, Domingues CC, Paula E, Marangoni S, Gattaz WF, Dias-Neto E, Novello JC: The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief Funct Genomic Proteomic 2007, 6: 70–75. 10.1093/bfgp/elm009View ArticlePubMed
  19. Chevallet M, Santoni V, Poinas A, Rouquié D, Fuchs A, Kieffer S, Rossignol M, Lunardi J, Garin J, Rabilloud T: New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis. Electrophoresis 1998, 19: 1901–1909. 10.1002/elps.1150191108View ArticlePubMed
  20. Henningsen R, Gale BL, Straub KM, DeNage DC: Application of zwitterionic detergents to the solubilization of integral membrane proteins for two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2002, 2: 1479–1488. 10.1002/1615-9861(200211)2:11<1479::AID-PROT1479>3.0.CO;2-AView ArticlePubMed
  21. Jiang L, He L, Fountoulakis M: Comparison of protein precipitation methods for sample preparation prior to proteomic analysis. J Chromatogr A 2004, 1023: 317–320. 10.1016/j.chroma.2003.10.029View ArticlePubMed
  22. López JL: Two-dimensional electrophoresis in proteome expression analysis. J Chromatogr B 2007, 849: 190–202. 10.1016/j.jchromb.2006.11.049View Article
  23. Fic E, Kedracka-Krok S, Jankowska U, Pirog A, Dziedzicka-Wasylewska M: Comparison of protein precipitation methods for various rat brain structures prior to proteomic analysis. Electrophoresis 2010, 31: 3573–3579. 10.1002/elps.201000197View ArticlePubMed
  24. Elias JE, Gygi SP: Target-decoy strategy for mass spectrometry-based proteomics. Methods Mol Biol 2010, 604: 55–71. 10.1007/978-1-60761-444-9_5View ArticlePubMed
  25. Campostrini N, Areces LB, Rapssilber J, Pietrogrande MC, Dondi F, Pastorino F, Ponzoni M, Righetti PG: Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. Proteomics 2005, 5: 2385–2395. 10.1002/pmic.200401253View ArticlePubMed
  26. Mahadevan LC, Whatley SA, Leung TKC, Lim L: The brain isoform of a key ATP-regulating enzyme, creatine Kinase, is a phosphoprotein. Biochem J 1984, 222: 139–144.View ArticlePubMed
  27. Cañas B, Piñeiro C, Calvo E, López-Ferrer D, Gallardo JM: Trends in sample preparation for classical and second generation proteomics. J Chromatogr A 2007, 1153: 235–258. 10.1016/j.chroma.2007.01.045View ArticlePubMed
  28. Braun RJ, Kinkl N, Beer M, Ueffing M: Two-dimensional electrophoresis of membrane proteins. Anal Bioanal Chem 2007, 389: 1033–1045. 10.1007/s00216-007-1514-6View ArticlePubMed
  29. Churchward MA, Butt RH, Lang JC, Hsu KK, Coorssen JR: Enhanced detergent extraction for analysis of membrane proteomes by two-dimensional gel electrophoresis. Proteome Sci 2005, 3: 5–15. 10.1186/1477-5956-3-5View ArticlePubMed
  30. Thomas PD, Campbell MJ, Kejariwal A, Huaiyu M, Karlak B, Daverman R, Diemer K, Muruganuian A, Narechania A: PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003, 13: 2129–2141. 10.1101/gr.772403View ArticlePubMed
  31. Das UN, Rao AA: Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis 2007, 14: 6–35.
  32. Choquette AC, Lemieux S, Tremblay A, Drapeau V, Bouchard C, Vohl M, Pérusse L: GAD2 gene sequence variations are associated with eating behaviours and weight gain in women from the Quebec family study. Physiol Behav 2009, 98: 505–510. 10.1016/j.physbeh.2009.08.004View ArticlePubMed
  33. Meyre D, Boutin P, Tounian A, Deweider M, Aout M, Jouret B, Heude B, Weill J, Tauber M, Tounian P, Froguel F: Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children? J Clin Endocrinol Metab 2005, 90: 2384–2390. 10.1210/jc.2004-1468View ArticlePubMed
  34. Montano MAE, Lera JPB, Gottlieb MGV, Schwanke CHA, Rocha MIUM, Manica-Cattani MF, Santos GF, Cruz IBM: Association between manganese superoxide dismutase (MnSOD) gene polymorphism and elderly obesity. Moll Cell Biochem 2009, 328: 33–40. 10.1007/s11010-009-0071-zView Article
  35. Alexandre-Gouabau MF, Bailly E, Moyon TL, Grit IC, Coupé B, Le Drean G, Rogniaux HJ, Parnet P: Postnatal growth velocity modulates alterations of proteins involved in metabolism and neuronal plasticity in neonatal hypothalamus in rats born with intrauterine growth restriction. J Nutr Biochem 2009. in press
  36. Sardinha FLC, Telles MM, Albuquerque KT, Oyama LM, Guimarães PAMP, Santos OFP, Ribeiro EB: Gender difference in the effect of intrauterine malnutrition on the central anorexigenic action of insulin in adult rats. Nutrition 2006, 22: 1152–1161. 10.1016/j.nut.2006.07.002View ArticlePubMed
  37. Pôrto LCJ, Sardinha FLC, Telles MM, Guimarães RB, Albuquerque KT, Andrade IS, Oyama LM, Nascimento CMO, Santos OFP, Ribeiro EB: Impairment of the serotonergic control of feeding in adult female rats exposed to intra-uterine malnutrition. Br J Nutr 2009, 101: 1255–1261. 10.1017/S0007114508061503View ArticlePubMed
  38. Kuhla B, Kuhla S, Rudolph PE, Albrecht D, Metges CC: Proteomics analysis of hypothalamic response to energy restriction in dairy cows. Proteomics 2007, 7: 3602–3617. 10.1002/pmic.200700248View ArticlePubMed
  39. Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS: Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 2000, 279: E838-E845.PubMed
  40. Perez JD, Arita DY, Costa H, Casarini DE: Proteomic analysis of contrast media-treated mesangial cell. The Open Proteomics Journal 2009, 2: 1–7. 10.2174/1875039700902010001View Article
  41. Pimentel GD, Dornellas APS, Rosa JC, Lira FS, Cunha CA, Boldarini VT, Souza GIH, Hirata AE, Nascimento CMON, Oyama LM, Watanabe RLH, Ribeiro EB: High-fat diets rich in soy or fish oil distinctly alter hypothalamic insulin signaling in rats. J Nutr Biochem 2011. In press

Copyright

© Pedroso et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement